npj Precision Oncology (Oct 2024)

Novel paediatric case of a spinal high-grade astrocytoma with piloid features in a patient with Noonan Syndrome

  • Jordan Staunton,
  • Pamela Ajuyah,
  • Angela Harris,
  • Chelsea Mayoh,
  • Marie Wong,
  • Megan Rumford,
  • Patricia J. Sullivan,
  • Paul G. Ekert,
  • Noemi Fuentes-Bolanos,
  • Mark J. Cowley,
  • Loretta M. S. Lau,
  • David S. Ziegler,
  • Paulette Barahona,
  • Neevika Manoharan

DOI
https://doi.org/10.1038/s41698-024-00734-3
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Noonan Syndrome (NS) is associated with an increased risk of low-grade central nervous system tumours in children but only very rarely associated with high-grade gliomas. Here we describe the first reported case of a spinal high-grade astrocytoma with piloid features (HGAP) in a child with NS. This case was a diagnostic and treatment dilemma, prior to whole-genome germline and tumour sequencing, tumour transcriptome sequencing and DNA methylation analysis. The methylation profile matched strongly with HGAP and sequencing identified somatic FGFR1 and NF1 variants and a PTPN11 germline pathogenic variant. Therapeutic targets were identified but also alterations novel to HGAP such as differential expression of VEGFA and PD-L1. The germline PTPN11 finding has not been previously described in individuals with HGAP. This case underscores the power of precision medicine from a diagnostic, therapeutic and clinical management perspective, and describes an association between HGAP and NS which has not previously been reported.